Belgian Economic Mission Norway

17–19 Jun 2024 | Norway

Christophe Deben

Professor University of Antwerp, co-founder DrugVision.AI and Orbits Oncology platforms

University of Antwerp

Antwerp, Belgium

4 profile visitsSpeaker

Prof. Dr. Christophe Deben, advancing high-throughput tumor organoid drug screening with AI-driven live-cell imaging.

About me

Group lead Tumoroid Screening Lab (University of Antwerp)

Head of UZA/UAntwerp tumor organoid biobank

Head of DrugVision.AI drug screening platform (www.drugvision.ai, University of Antwerp)

Co-founder Orbits Oncology image and data analysis platform for high-throughput organoid drug screening (www.orbits-oncology.com, spin-off University of Antwerp)

Co-founder Sightera Biosciences for AI drug development (www.sightera-biosciences.com, spin-off in development University of Antwerp)

My organisation

University of Antwerp

https://www.uantwerpen.be/en/

Sector: Chemicals, Pharmaceuticals and Life sciences

Social media

Skills

  • Tumor Organoids
  • Cancer research
  • Live-cell imaging
  • High-throughput drug screening

Interests

  • AI in translational cancer research
  • High-throughput drug screening

Speaker sessions (1)

Monday, 17 June 2024